Delivery Order SPE2DB22D9304-SPE2DB24FSSZ0
Award Date
7/22/24
Potential Completion Date
8/12/24
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) for the delivery of XOLAIR 300 MG/2 ML AUTOINJECT 2ML medical supplies. The $3,424.46 firm fixed-price delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The $6,848.92 contract is for the delivery of 4,566,869,571 units of Xolair 300 mg/2 ml autoinjector. This delivery order is part of a larger, single-award Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group valued at $499,999,999, which enables the DLA to place orders for a...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of XOLAIR 150 MG/ML AUTOINJECTORML to the Defense Logistics Agency's (DLA) Medical Supply Chain division. The $4,280.55 firm fixed-price delivery order is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS holds with the DLA under the SPE2DB program. This single-award IDC allows the DLA to issue delivery orders for a comprehensive range of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $3,424.46 for the supply of 4565853377 XOLAIR 300 MG/2 ML AUTOINJECT 2ML. The contract has a firm fixed-price pricing type and an ultimate completion date of October 7, 2024. The award is associated with a larger indefinite delivery contract (IDC) held by DMS Pharmaceutical Group Inc. with the Defense Logistics Agency (DLA) under the SPE2DB...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $2,568.33 for the supply of XOLAIR 150 MG/ML AUTOINJECTORML. The award was made by the Defense Logistics Agency (DLA), a defense agency, under the SPE2DB program, which is a multi-award Indefinite Delivery Contract (IDC) with a ceiling value of $499,999,999 and valid through November 2026. DMS Pharmaceutical Group holds this IDC, enabling the DLA to issue firm fixed-price...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB program. The contract, valued at $34,244.60, is for the provision of Xolair 300 mg/2 ml autoinjector to the DLA for distribution to various U.S. Department of Defense (DoD) healthcare facilities worldwide. The contract has an ultimate completion date of August 19, 2024. This award is part of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,712.23 firm fixed-price delivery order is for the supply of XOLAIR 300 MG/2 ML AUTOINJECT 2ML, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a $3,424.46 firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB Indefinite Delivery Contract (IDC). The contract is for the delivery of Xolair 300 mg/2 ml autoinjectors to support the medical supply needs of military healthcare facilities. The IDC, valued at $499,999,999, enables the DLA to issue delivery orders for a wide range of pharmaceutical products, including...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,424.46 firm fixed-price delivery order is for the supply of XOLAIR 300 MG/2 ML AUTOINJECT 2ML, a specialty pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a Delivery Order (DO) valued at $37,137.60 with a firm fixed price pricing type. The award is under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) worth $499,999,999 and valid through November 2026. The contract is for the delivery of XOLAIR 150 MG/ML SYRINGEML, a specialized pharmaceutical product, to support the recurring medical supply...